As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.
Coronavirus: Can Companies Achieve Vaccine Ambition?
J&J Best Placed To Accelerate Timelines
